INVIVO PERSISTENCE OF A HIV-1-ENCODED HLA-B27-RESTRICTED CYTOTOXIC LYMPHOCYTE-T EPITOPE DESPITE SPECIFIC INVITRO REACTIVITY

被引:80
作者
MEYERHANS, A
DADAGLIO, G
VARTANIAN, JP
LANGLADEDEMOYEN, P
FRANK, R
ASJO, B
PLATA, F
WAINHOBSON, S
机构
[1] INST PASTEUR,RETROVIROL MOLEC LAB,28 RUE DR ROUX,F-75724 PARIS 15,FRANCE
[2] GESELL BIOTECHNOL FORSCH GMBH,W-3300 BRAUNSCHWEIG,GERMANY
[3] KAROLINSKA INST,STATE BACTERIOL LAB,S-10401 STOCKHOLM 60,SWEDEN
[4] INST PASTEUR,IMMUNOPATHOL RETROVIRUS LAB,F-75724 PARIS 15,FRANCE
关键词
D O I
10.1002/eji.1830211051
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A large number of human immunodeficiency virus type 1 (HIV-1) specific HLA-restricted cytotoxic T cell (CTL) epitopes have been mapped, including an HLA-B27-restricted immunodominant epitope within p25gag. Accordingly, this segment of the HIV-1 provirus was amplified by the polymerase chain reaction from DNA derived from fresh uncultured peripheral blood mononuclear cells (PBMC) of four HLA-B27 HIV-1-infected individuals. In all cases the majority of infected PBMC bore sequences encoding the HLA-B27-restricted peptide. CTL escape mutants had not accumulated in vivo 8 and 14 months later despite demonstrable CTL activity in vitro. These data emphasize the importance of silently infected lymphocytes in evading immune surveillance.
引用
收藏
页码:2637 / 2640
页数:4
相关论文
共 31 条
[1]   RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA [J].
ALBERT, J ;
ABRAHAMSSON, B ;
NAGY, K ;
AURELIUS, E ;
GAINES, H ;
NYSTROM, G ;
FENYO, EM .
AIDS, 1990, 4 (02) :107-112
[2]   HUMAN CYTOMEGALOVIRUS-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T - REQUIREMENTS FOR INVITRO GENERATION AND SPECIFICITY [J].
BORYSIEWICZ, LK ;
MORRIS, S ;
PAGE, JD ;
SISSONS, JGP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1983, 13 (10) :804-809
[3]  
BRINCHMANN JE, 1990, J IMMUNOL, V144, P2961
[4]   T-IMMUNOGENIC PEPTIDES ARE CONSTITUTED OF RARE SEQUENCE PATTERNS - USE IN THE IDENTIFICATION OF T-EPITOPES IN THE HUMAN IMMUNODEFICIENCY VIRUS GAG PROTEIN [J].
CLAVERIE, JM ;
KOURILSKY, P ;
LANGLADEDEMOYEN, P ;
CHALUFOURPROCHNICKA, A ;
DADAGLIO, G ;
TEKAIA, F ;
PLATA, F ;
BOUGUELERET, L .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (10) :1547-1553
[5]   AN ANTIGENIC PEPTIDE OF THE HIV-1 NEF PROTEIN RECOGNIZED BY CYTOTOXIC LYMPHOCYTE-T OF SEROPOSITIVE INDIVIDUALS IN ASSOCIATION WITH DIFFERENT HLA-B MOLECULES [J].
CULMANN, B ;
GOMARD, E ;
KIENY, MP ;
GUY, B ;
DREYFUS, F ;
SAIMOT, AG ;
SERENI, D ;
LEVY, JP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (12) :2383-2386
[6]   SIMULTANEOUS MULTIPLE PEPTIDE-SYNTHESIS UNDER CONTINUOUS-FLOW CONDITIONS ON CELLULOSE PAPER DISKS AS SEGMENTAL SOLID SUPPORTS [J].
FRANK, R ;
DORING, R .
TETRAHEDRON, 1988, 44 (19) :6031-6040
[7]  
GOODENOW M, 1989, J ACQ IMMUN DEF SYND, V2, P344
[8]  
HEALY F, 1989, J IMMUNOL, V143, P2357
[9]  
HOFFENBACH A, 1989, J IMMUNOL, V142, P452
[10]   STRUCTURAL HOMOLOGIES BETWEEN 2 HLA B27-RESTRICTED PEPTIDES SUGGEST RESIDUES IMPORTANT FOR INTERACTION WITH HLA-B27 [J].
HUET, S ;
NIXON, DF ;
ROTHBARD, JB ;
TOWNSEND, A ;
ELLIS, SA ;
MCMICHAEL, AJ .
INTERNATIONAL IMMUNOLOGY, 1990, 2 (04) :311-316